Examples of successful FY 2018 COAP grant application project narratives:
Fact Sheet: Justice Department is Awarding Almost $320 Million to Combat Opioid Crisis
FY 2017 Comprehensive Opioid Abuse Site-based Program Awards Category 1: Overdose Outreach ProjectsCategory 2: Technology-assisted Treatment ProjectsCategory 3: System-level Diversion and Alternatives to Incarceration ProjectsCategory 4: Statewide Planning, Coordination and Implementation ProjectsCategory 5: Harold Rogers Prescription Drug Monitoring ProgramCategory 6: Data-driven Responses to Opioid Misuse Projects
COAP TTA cooperative agreement recipientsBJA selected four training and technical assistance providers to provide assistance and a repository of information to states, local jurisdictions, and tribal territories to combat the opioid epidemic.
*The COAP TTA collaborative also supports the President’s Commission on Combating Drug Addiction and the Opioid Crisis by informing best practices for addiction prevention and the use and effectiveness of state prescription drug monitoring programs, and by improving access to and availability of treatment services and overdose reversal throughout the country.
BJA COAP Grant Program Performance Measure Matrix
Combined Performance Measure Questionnaires for COAP
BJA Policy on Use of Harold Rogers Prescription Drug Monitoring Program (HRPDMP) Funding to Support Interstate Data Sharing Activities (May 30, 2012)
Prescription Drug Monitoring Programs: Critical Information Sharing Enabled by National Standards
PDMP FAQs: Interstate Data Sharing and Permitted Use of Funds
Beginning in FY 2002, Congress appropriated funding to the U.S. Department of Justice to support the Prescription Drug Monitoring Program. Prescription monitoring programs help prevent and detect the diversion and abuse of pharmaceutical controlled substances, particularly at the retail level where no other automated information collection system exists. States that have implemented prescription monitoring programs have the capability to collect and analyze prescription data much more efficiently than states without such programs, where the collection of prescription information requires the manual review of pharmacy files, a time-consuming and invasive process.The purpose of the Prescription Drug Monitoring Program is to enhance the capacity of regulatory and law enforcement agencies to collect and analyze controlled substance prescription data. The program focuses on providing help for states that want to establish a prescription drug monitoring program. Resources are also available to states that wish to expand their existing programs. Program objectives include:
LegislationThe Prescription Drug Monitoring Program was created by the FY 2002 U.S. Department of Justice Appropriations Act (Public Law 107-77).
National Recovery Month (September) National Recovery Month (Recovery Month) is a national observance that educates Americans on the fact that addiction treatment and mental health services can enable those with a mental and/or substance use disorder to live a healthy and rewarding life. The observance’s main focus is to laud the gains made by those in recovery from these conditions, just as we would those who are managing other health conditions such as hypertension, diabetes, asthma, and heart disease. Recovery Month spreads the positive message that behavioral health is essential to overall health, prevention works, treatment is effective, and people can and do recover. Recovery Month, now in its 30th year, highlights individuals who have reclaimed their lives and are living happy and healthy lives in long-term recovery and also honors the prevention, treatment, and recovery service providers who make recovery possible. Recovery Month promotes the message that recovery in all its forms is possible, and also encourages citizens to take action to help expand and improve the availability of effective prevention, treatment, and recovery services for those in need.
Join BJA in celebrating the 30th anniversary of National Recovery Month. For more information on how to participate, visit the National Recovery Month website.
BJA's COAP's Strategic FocusCOAP’s strategic focus on combatting the opioid epidemic reflects the Attorney General’s commitment to reduce the number of fatal overdoses and to protect the American people. Broadly, COAP’s goals are to: (1) reduce opioid abuse and misuse and the number of overdose fatalities; and (2) support the implementation and enhancement of prescription drug monitoring programs (PDMPs). COAP focuses on systemwide initiatives, as well as innovative approaches, to promote substance abuse treatment and recovery support. These concepts are rooted in the Sequential Intercept Model. The model provides a conceptual framework that communities can use when considering the interface between the criminal justice and substance abuse treatment systems. Within the criminal justice system, there are numerous intercept points, which are opportunities for linkage to services and for prevention of further involvement with the criminal justice system. The model shows the paths an individual may take through the criminal justice system; where the intercept points fall; and areas that communities can target for diversion, engagement, and reentry. In structuring COAP, BJA leaders have focused on effective policy strategies that include the following:
Funding Options for Prescription Drug Monitoring ProgramsTo help Prescription Drug Monitoring Programs (PDMPs) identify funding options which may assist them in remaining operational and fulfill their purpose in a time of shrinking state budgets, BJA's PDMP Training and Technical Assistance Center, operated by Brandeis University, has developed a guide to inform PDMP administrators, policymakers, legislative representatives, and other interested stakeholders about funding mechanisms currently in use across the country. The guide also suggests other funding possibilities a PDMP may wish to consider to ensure sustainability and program enhancement.
See More Funding
BJA is pleased to announce the newly developed COAP Resource Center, which houses a wide array of resources, including newsletters, webinars, podcasts, publications, and training opportunities. COAP grantees and opioid abuse/misuse treatment providers can request individualized training and technical assistance in the areas of peer recovery, leveraging of key public health and public safety data sets, reduction of opioid misuse and overdose fatalities, and prescription drug monitoring. Practitioners and administrators interested in BJA funding can also review detailed program summaries from each grantee awarded under the six categories of the BJA COAP solicitation.
The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) at Brandeis University provides a comprehensive array of services, support, resources, and strategies to PDMPs, federal partners and other stakeholders to further the efforts and effectiveness of PDMPs in combating the misuse, abuse and diversion of prescription drugs.
Additional COAP TTA provider websites are forthcoming for the Institute for Intergovernmental Research, Advocates for Human Potential, and Altarum Institute.
Comprehensive Opioid Abuse Program (COAP) Resource Center
Drug Enforcement Administration (DEA): Diversion Control Division
National Association of Drug Diversion Investigators (NADDI)
National Alliance for Model State Drug Laws (NAMSDL)
National Conference of State Legislatures (NCSL)
More BJA Publications
See More FAQs
Frequently Asked Questions about the Office of Justice Programs (OJP) Bureau of Justice Assistance (BJA) Fiscal Year (FY) 2017 Comprehensive Opioid Abuse Site-based and Training and Technical Assistance Grant Programs
PDMP TTAC Newsletters:
810 Seventh Street NW, Washington, D.C. 20531
For Government Use Only